Colorectal cancer vaccines: What we know and what we don't yet know

Seminars in Oncology

Volumn 32, Issue 1 SPEC. ISS., 2005, Pages 76-84

  Von Mehren, Margaret ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; B7 ANTIGEN; BCG VACCINE; CANCER VACCINE; CAP 1 CARCINOEMBRYONIC ANTIGEN PEPTIDE; CAP 1 PEPTIDE; CARCINOEMBRYONIC ANTIGEN; CARCINOEMBRYONIC ANTIGEN 6D TRICOM; CARCINOEMBRYONIC ANTIGEN B7 ANTIGEN; CREATINE KINASE; DNA VACCINE; FLUOROURACIL; FREUND ADJUVANT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 96; HEPATITIS B SURFACE ANTIGEN; IMMUNOLOGICAL ADJUVANT; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MONOCLONAL ANTIBODY 3H1; MONOCLONAL ANTIBODY 708; OLIGONUCLEOTIDE; RECOMBINANT ANTIGEN; RECOMBINANT CARCINOEMBRYONIC ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG; VIRUS VECTOR;

ADOPTIVE IMMUNOTHERAPY; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGENICITY; CANARYPOX VIRUS; CANCER ADJUVANT THERAPY; CANCER CELL CULTURE; CANCER CONTROL; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; CREATINE KINASE BLOOD LEVEL; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DNA TRANSFECTION; DRUG EFFECT; DRUG SAFETY; DRUG TOXICITY; ERYTHEMA; FATIGUE; FLU LIKE SYNDROME; FOWLPOX VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOGENICITY; IMMUNOMODULATION; INJECTION SITE REACTION; LIVER METASTASIS; LYMPHOPROLIFERATIVE DISEASE; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PRURITUS; RECTUM CANCER; REVIEW; TREATMENT OUTCOME; VACCINIA VIRUS; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT; VIRUS REPLICATION;

EID: 13844294268     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2004.09.033     Document Type: Article

References (80)

1. D.M. Pardoll Cancer vaccines Nature Med 4 suppl 5 1998 525 531
2. J.Y. Liu, Y.Q. Wei, L. Yang Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2 Blood 102 2003 1815 1823
3. Q.M. He, Y.Q. Wei, L. Tian Inhibition of tumor growth with a vaccine based on xenogeneic homologous fibroblast growth factor receptor-1 in mice J Biol Chem 278 2003 21831-21816
4. W. Zimmermann, B. Weber, B. Ortlieb Chromosomal localization of the carcinoembryonic antigen gene family and differential expression in various tumors Cancer Res 48 1988 2550 2554
5. J.E. Shively, J.D. Beatty CEA-related antigens Molecular biology and clinical significance Crit Rev Oncol Hematol 2 1985 355 399
6. J.M. Esteban, B. Felder, C. Ahn Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients Cancer 74 1994 1575 1583
7. C. Wagener, P. Petzold, W. Kohler Binding of five monoclonal anti-CEA antibodies with different epitope specificities to various carcinoma tissues Int J Cancer 33 1984 469 475
8. J.K. Chung, M.C. Lee, H.K. Chung Concentration and distribution of tumor associated antigens TAG-72 and CEA in stomach cancer Ann Nucl Med 9 1995 7 13
9. F.T. Brezicka, S. Olling, B. Bergman Coexpression of ganglioside antigen Fuc-GM1, neural-cell adhesion molecule, carcinoembryonic antigen, and carbohydrate tumor-associated antigen CA 50 in lung cancer Tumour Biol 13 1992 308 315
10. J.W. Yewdell, J.R. Bennink The binary logic of antigen processing and presentation to T cells Cell 62 1990 203 206
11. Y.S. Hahn, B. Yang, T.J. Braciale Regulation of antigen processing and presentation to class I MHC restricted CD8+ T lymephocytes Immunol Rev 151 1996 31 49
12. N.K. Jerne Towards a network theory of the immune system Ann Immunol 125C 1974 373 389
13. J. Lindenmann Speculations on idiotypes and homobodies Ann Immunol 124 1973 171 184
14. D.L. Shawler, R.M. Bartholomew, M.A. Garrett Antigenic and immunologic characterization of an allogeneic colon carcinoma vaccine Clin Exp Immunol 129 2002 99 106
15. R.E. Sobol, D.L. Shawler, C. Carson Interleukin 2 gene therapy of colorectal carcinoma with autologous irradiated tumor cells and genetically engineered fibroblasts A phase I study Clin Cancer Res 5 1999 2359 2365
16. H.C. Hoover Jr, J.S. Brandhorst, L.C. Peters Adjuvant active specific immunotherapy for human colorectal cancer 6.5-year median follow-up of a phase III prospectively randomized trial J Clin Oncol 11 1993 390 399
17. J. Harris, L. Ryan, G. Adams Survival and relapse in adjuvant autologous tumour vaccine therapy for Dukes B and C colon cancer-EST 5283 Proc Am soc Clin Oncol 13 1994 294 (abstr)
18. J.B. Vermorken, A.M. Claessen, H. van Tinteren Active specific immunotherapy for stage II and stage III human colon cancer A randomized trial Lancet 353 1999 345 350
19. S. Zaremba, E. Barzaga, M. Zhu Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen Cancer Res 57 1997 4570 4577
20. E. Huarte, P. Sarobe, J. Lu Enhancing immunogenicity of a CTL epitope from carcinoembryonic antigen by selective amino acid replacements Clin Cancer Res 8 2002 2336 2344
21. C. Palena, P. Arlen, Zeytin Enhanced expression of lymphotactin by CD8+ T cells is selectively induced by enhancer agonist peptides of tumor-associated antigens Cytokine 24 2003 128 142
22. A. Samanci, Q. Yi, J. Fagerberg Pharmacological administration of granulocyte/macrophage-colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen Cancer Immunol Immunother 47 1998 131 142
23. M.A. Morse, Y. Deng, D. Coleman A phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen Clin Cancer Res 5 1999 1331 1338
24. S.E. Alters, J.R. Gadea, M. Sorich Dendritic cells pulsed with CEA peptide induce CEA-specific CTL with restricted TCR repertoire J Immunother 21 1998 17 26
25. S.K. Nair, S. Hull, D. Coleman Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA Int J Cancer 82 1999 121 124
26. P. Srivastava Interaction of heat shock proteins with peptides and antigen presenting cells Chaperoning of the innate and adaptive immune responses Annu Rev Immunol 20 2002 395 425
27. F.U. Hartl, M. Hayer-Hartl Molecular chaperones in the cytosol From nascent chain to folded protein Science 295 2002 1852 1858
28. L. Rivoltini, C. Castelli, M. Carrabba Human tumor-derived heat shock protein 96 mediates in vitro activation and in vivo expansion of melanoma- and colon carcinoma-specific T cells J Immunol 171 2002 3467 3474
29. V. Mazzaferro, J. Coppa, M.G. Carrabba Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer Clin Cancer Res 9 2003 3235 3245
30. L. Durrant, G. Denton, E. Jacobs An idiotypic replica of carcinoembryonic antigen inducing cellular and humoral responses directed against human colorectal tumours Int J Cancer 50 1992 811 816
31. K.A. Foon, M. Chakraborty, W.J. John Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccine J Clin Invest 96 1995 334 342
32. K.A. Foon, W.J. John, M. Chakraborty Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen Clin Cancer Res 3 1997 1267 1276
33. S.K. Chatterjee, P.K. Tripathi, M. Chakraborty Molecular mimicry of carcinoembryonic antigen by peptides derived from the structure of an anti-idiotype antibody Cancer Res 58 1998 1217 1224
34. K.A. Foon, W.J. John, M. Chakraborty Clinical and immune responses in resected colon cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen J Clin Oncol 17 1999 2889 2895
35. N.B. Baral, A. Saha, S.K. Chatterjee Immunostimulatory CpG oligonucleotides enhance the immune response of anti-idiotype vaccine that mimics carcinoembryonic antigen Cancer Immunol Immunother 52 2003 317 327
36. A.D. Cohen, J.D. Boyer, D.B. Weiner Modulating the immune response to genetic immunization FASEB J 12 1998 1611 1626
37. R.M. Conry, S.A. White, P.N. Fultz Polynucleotide immunization of nonhuman primates against carcinoembryonic antigen Clin Cancer Res 4 1998 2903 2912
38. R. Conry, D. Curiel, T. Strong Safety and immunogenicity of a DNA vaccine encoding carcinoembryonic antigen and hepatitis B surface antigen in colorectal carcinoma patients Clin Cancer Res 8 2002 2782 2787
39. S.K. Nair, D. Boczkowski, M. Morse Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA Nature Biotechnol 16 1998 364 369
40. S. Nair, M. Morse, D. Boczkowski Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells Ann Surg 235 2002 540 549
41. D. McAneny, C.A. Ryan, R.M. Beazley Results of a phase I trial of a recombinant vaccinia virus that expresses carcinoembryonic antigen in patients with advanced colorectal cancer Ann Surg Oncol 3 1996 495 500
42. R.M. Conry, M.B. Khazaeli, M.N. Saleh Phase I trial of a recombinant vaccinia virus encoding carcinoembryonic antigen in metastatic adenocarcinoma Comparison of intradermal versus subcutaneous administration Clin Cancer Res 5 1999 2330 2337
43. R. Conry, K. Alen, S. Lee Human autoantibodies to carcinoembryonic antigen (CEA) induced by a vaccinia-CEA vaccine Clin Cancer Res 6 2000 34 41
44. K.Y. Tsang, S. Zaremba, C.A. Nieroda Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine J Natl Cancer Inst 87 1995 982 990
45. J. Taylor, C. Trimarchi, R. Weinberg Efficacy studies on a canary pox-rabies recombinant virus Vaccine 9 1991 190 193
46. J. Taylor, R. Weinberg, J. Tartaglia Nonreplicating viral vectors as potential vaccines Recombinant canary pox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins Virology 187 1992 321 328
47. J. Nelson The behavior of pox viruses in the respiratory tract. IV. The nasal instillation of fowlpox virus in chickens and in mice J Exp Med 74 1941 203 211
48. S.J. Kent, A. Zhao, S.J. Best Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus J Virol 72 1998 10180 10188
49. B.E. Coupar, T. Teo, D.B. Boyle Restriction endonuclease mapping of the fowlpox virus genome Virology 179 1990 159 167
50. X. Liu, D. Peng, X. Wu A recombinant fowlpox virus vaccine expressing glycoprotein B gene from CVI988/Rispens strain of MDV Protection studies in different chickens Acta Virol 43 1999 201 204
51. H.G. Heine, A.J. Foord, P.L. Young Recombinant fowlpox virus vaccines against Australian virulent Marek's disease virus Gene sequence analysis and comparison of vaccine efficacy in specific pathogen free and production chickens Virus Res 50 1997 23 33
52. M. Girard, B. Meignier, F. Barre-Sinoussi Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1 J Virol 69 1995 6239 6248
53. J. Tartaglia, O. Jarrett, J.C. Neil Protection of cats against feline leukemia virus by vaccination with a canary pox virus recombinant, ALVAC-FL J Virol 67 1993 2370 2375
54. M.A. Egan, W.A. Pavlat, J. Tartaglia Induction of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T lymphocyte responses in seronegative adults by a nonreplicating, host-range-restricted canary pox vector (ALVAC) carrying the HIV-1MN env gene J Infect Dis 171 1995 1623 1627
55. M. Cadoz, A. Strady, B. Meignier Immunization with canary pox virus expressing rabies glycoprotein Lancet 339 1992 1429 1432
56. H.L. Robinson, D.C. Montefiori, R.P. Johnson Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations Nat Med 5 1999 526 534
57. J.L. Marshall, M.J. Hawkins, K.Y. Tsang Phase I study in cancer patients of a replication-defective avipox recombinant vaccine that expresses human carcinoembryonic antigen J Clin Oncol 17 1999 332 337
58. M.Z. Zhu, J. Marshall, D. Cole Specific cytolytic T-cell responses to human CEA from patients immunized with recombinant avipox-CEA vaccine Clin Cancer Res 6 2000 24 33
59. J.L. Marshall, R.J. Hoyer, M.A. Toomey Phase I study in cancer patients of a diversified prime and boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic immune responses J Clin Oncol 20 2000 2251 2266
60. M. von Mehren, P. Arlen, K.Y. Tsang Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomas Clin Cancer Res 6 2000 2219 2228
61. M. von Mehren, P. Arlen, J. Gulley The influence of GM-CSF and prior chemotherapy on the immunologic response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma Clin Cancer Res 7 2001 1181 1191
62. H. Horig, D.S. Lee, W. Conkright Phase I clinical trial of a recombinant canary poxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule Cancer Immunol Immunother 49 2000 504 514
63. R. Rothlein, M. Dustin, S. Marlin A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1 J Immunol 37 1986 1270 1274
64. M.W. Makgoba, M.E. Sanders, S. Shaw The CD2-LFA-3 and LFA-1-ICAM pathways Relevance to T-cell recognition Immunol Today 10 1989 417 422
65. R.M. Steinman The dendritic cell system and its role in immunogenicity Annu Rev Immunol 9 1991 271 296
66. M.L. Dustin, T.A. Springer Role of lymphocyte adhesion receptors in transient interactions and cell locomotion Annu Rev Immunol 9 1991 27 66
67. B. Bierer, J. Barbosa, S. Herrmann Interaction of CD2 with its ligand, LFA-3, in human T cell proliferation J Immunol 140 1988 3358 3363
68. J.W. Hodge, H. Sabzevari, A. Gomez A triad of costimulatory molecules synergize to amplify T-cell activation Cancer Res 59 1999 5800 5807
69. M. von Mehren Tumor vaccines 2003 Presented at the 4th Annual Perspectives in Colorectal Cancer, Washington, DC, September 12
70. J. Marshall, L. Odogwu, J. Hwang A phase I study of sequential vaccinations with fowlpox-CEA (6D)-TRICOM (B7.1/ICAM-1/LFA-3) alone, and sequentially with vaccinia-CEA (6D)-TRICOM and GM-CSF in patients with CEA-expressing carcinomas Proc Am Soc Clin Oncol 22 2003 165 (abstr 662)
71. T. Jones, A. Stern, R. Lin Potential role of granulocyte-macrophage colony-stimulating factor as vaccine adjuvant Eur J Clin Microbiol Infect Dis 13 suppl 1994 S47 S53
72. P.J. Morrissey, L. Bressler, L.S. Park Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells J Immunol 139 1987 1113 1119
73. G. Dranoff, E. Jaffee, A. Lazenby Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity Proc Natl Acad Sci U S A 90 1993 3539 3543
74. S. Prete, A. Aquino, G. Masci Drug-induced changes of carcinoembryonic antigen expression in human cancer cells Effects of 5-fluorouracil J Pharmacol Exp Ther 279 1996 1574 1581
75. A. Aquino, S. Prete, J. Greiner Effect of the combined treatment with 5-fluorouracil, gamma-interferon or folinic acid on carcinoembryonic antigen expression in colon cancer cells Clin Cancer Res 4 1998 2473 2481
76. P.S. Linsley, W. Brady, M. Urnes CTLA-4 is a second receptor for the B cell activation antigen B7 J Exp Med 174 1991 561 569
77. L. Bugeon, M. Dallman Costimulation of T cells Am J Respir Crit Care Med 162 2000 S164 S168
78. E. Greenfield, K. Nguyen, V. Kuchroo CD28/B7 costimulation A review Crit Rev Immunol 18 1998 389 418
79. C. Chambers, J. Allison Co-stimulation in T cell responses Curr Opin Immunol 9 1997 396 404
80. J.S. Weber, J. Snively, S. Sian Phase I trial of antibody to CTLA-4 (MDX-010) with melanoma peptides/Ifa for resected stages III/IV melanoma Proc Am Soc Clin Oncol 22 2003 710 (abstr 2853)